Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations

PHASE3CompletedINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

April 21, 2017

Study Completion Date

April 21, 2017

Conditions
Asthma
Interventions
DRUG

Fluticasone 44 mcg

Fluticasone is an inhaled corticosteroid

DRUG

Fluticasone 220 mcg

Fluticasone is an inhaled corticosteroid

Trial Locations (18)

15212

Allegheny General Hospital, Pittsburgh

15224

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

27157

Wake Forest University Health Sciences, Winston-Salem

30322

Emory University, Atlanta

32207

Nemours Children's Clinic, Jacksonville

32827

Nemours Children's Clinic, Orlando

44106

Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland

53972

University of Wisconsin, Madison

60612

Rush University Medical Center/Stroger Hospital, Chicago

University of Illinois at Chicago, Chicago

60614

Ann and Robert H. Lurie Children's Hospital, Chicago

63110

St. Louis Children's Hospital, St Louis

Washington University, St Louis

80206

National Jewish Health, Denver

85724

University of Arizona College of Medicine, Tucson

94143

UCSF Benioff Children's Hospital, San Francisco

94609

Children's Hospital & Research Center Oakland, Oakland

02115

Children's Hospital Boston, Boston

All Listed Sponsors
lead

Milton S. Hershey Medical Center

OTHER

NCT02066129 - Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations | Biotech Hunter | Biotech Hunter